Oscar Health, Inc.

NYSE:OSCR

Medical - Healthcare Plans

Healthcare
$27.57 +0.18%

+$0.05 today

Market cap
$7.15B
Beta
2.39
P/E (TTM)
-214.2
EPS (TTM)
-$0.13
52W Low $10.69High $29.81

Volume 7.38M

Average 7.51M

OSCR Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Oscar Health, Inc.NYSE: OSCR

Income Tax Expense · Q2 FY2026 · quarter ended Jun 2026

Income tax expense turns positive

Q2 FY2026 income tax expense was $21.18M, compared with -$5.05M a year earlier. Trailing-twelve-month income tax expense was $38.88M.

Context

  • Income tax expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly income tax expense holds near $21.18M or moves back toward the trailing-twelve-month quarterly average of $9.72M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$21.18M+7.3% QoQ
Last fiscal yearDec 2025
$5.61M-23.3% YoY
LTMJun 2026
$38.88M+316.6% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+519.9%——
1 year-23.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Tax Expense history

USD · from the income statement

Latest · FY2025
5.61M USD
Year-over-year change
-23.3%
4-year CAGR
+60.4%

Income Tax Expense vs competitors

How OSCR compares with its peers on the latest reported figures

  • OSCR's LTM Jun 2026 income tax expense of $38.88M is the 5th highest of the 8 companies compared; the peer median is $474.04M.
  • Its year-over-year change of +316.6% is the highest of 7, against a peer median of -38.1%.
  • Income tax expense amounts to 0.3% of revenue for OSCR, versus a peer median of 0.2%.
OSCR Competitors Peer median
Income Tax Expense for OSCR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CICigna CorporationLTM Sep 2026$1.59B +11.5%-5.9%0.6%
ELVElevance Health Inc.LTM Sep 2026$1.15B -27.1%-15.1%0.6%
CVSCVS Health CorporationLTM Jun 2026$916M -54.3%-35.3%0.2%
CNCCentene CorporationLTM Jun 2026$474.04M -33.4%—0.2%
OSCROscar Health, Inc.LTM Jun 2026$38.88M +316.6%—0.3%
MOHMolina Healthcare, Inc.LTM Sep 2026$7M -97.4%-24.4%0.0%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$24K -42.9%-61.1%0.0%
CLOVClover Health Investments, Corp.LTM Jun 2026$0 ——0.0%
Peer median (excluding OSCR) $474.04M-38.1%-24.4%0.2%

Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.92B4.13B5.86B9.18B11.7B
Cost of Revenue004.64B7.33B10.02B
Gross Profit1.92B4.13B1.22B1.84B1.68B
Gross Margin100.0%100.0%20.8%20.1%14.4%
Research & Development00000
Selling, General & Admin265.08M1.42B002.05B
Operating Expenses2.49B4.74B1.46B1.79B2.08B
Depreciation & Amortization14.61M15.28M30.69M32.15M28.89M
EBITDA(551.26M)(572.17M)(212M)89.31M(391.05M)
EBITDA Margin-28.7%-13.9%-3.6%1.0%-3.3%
Operating Income(570.58M)(610.08M)(235.62M)57.27M(396.36M)
Operating Margin-29.7%-14.8%-4.0%0.6%-3.4%
Interest Income00000
Interest Expense4.72M22.62M24.6M23.73M17.6M
Other Income / Expenses00(31.69M)(23.84M)(40.94M)
Income Before Tax(570.58M)(610.08M)(267.3M)33.43M(437.3M)
Pre-Tax Margin-29.7%-14.8%-4.6%0.4%-3.7%
Income Tax Expense846K(523K)3.29M7.31M5.61M
Net Income(572.61M)(606.28M)(270.73M)25.43M(443.15M)
Net Margin-29.8%-14.7%-4.6%0.3%-3.8%
EPS (Basic)(3.19)(2.85)(1.22)0.11(1.69)
EPS (Diluted)(3.19)(2.85)(1.22)0.10(1.69)
Weighted Avg Shares178.97M212.47M221.66M240.39M262.39M
Weighted Avg Shares (Diluted)178.97M212.47M221.66M265.85M262.39M

Oscar Health, Inc.

NYSE:OSCR

Intrinsic Alpha fair value

Locked

Current Price

$27.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.